US5652105A
(en)
*
|
1995-07-28 |
1997-07-29 |
Health Research, Inc. |
Substrate for detection of mammalian 5-C-DNA methyltransferase
|
DE69708878T2
(de)
*
|
1996-05-22 |
2002-07-25 |
Univ Montreal Mcgill |
Spezifische inhibitoren vom dna-methyltransferaseenzym
|
US6268137B1
(en)
|
1996-05-22 |
2001-07-31 |
Methylgene, Inc. |
Specific inhibitors of DNA methyl transferase
|
US7138384B1
(en)
|
1997-08-29 |
2006-11-21 |
The Regents Of The University Of California |
Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
|
JP2001522607A
(ja)
*
|
1997-11-12 |
2001-11-20 |
マクギル・ユニヴァーシティ |
Dnaデメチラーゼおよびその治療および診断用途
|
DE19754482A1
(de)
*
|
1997-11-27 |
1999-07-01 |
Epigenomics Gmbh |
Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
|
US7026155B2
(en)
*
|
1999-02-02 |
2006-04-11 |
Regents Of The University Of California |
Method of reducing bacterial proliferation
|
CA2291367A1
(en)
*
|
1999-12-06 |
2001-06-06 |
Isabelle Henry |
Genetic constructions having a reduced or an increased number of epigenetic control regions and methods of use thereof
|
DE10010282B4
(de)
|
2000-02-25 |
2006-11-16 |
Epigenomics Ag |
Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben
|
WO2001092565A2
(en)
|
2000-04-06 |
2001-12-06 |
Epigenomics Ag |
Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription
|
US7384759B2
(en)
*
|
2000-12-11 |
2008-06-10 |
The Salk Institute For Biological Studies |
Methods and compositions for determinig enzymatic activity and specificity of chalcone O-methyltransferases
|
EP1402071A4
(de)
*
|
2001-06-08 |
2005-12-14 |
Us Genomics Inc |
Verfahren und produkte zur analyse von nukleinsäuren auf grundlage des methylierungsstatus
|
JP2005508885A
(ja)
*
|
2001-07-31 |
2005-04-07 |
ザ ステイト オブ オレゴン, アクティング バイ アンド スルー ザ ステイト ボード オブ ハイヤー エデュケイション オン ビハーフ オブ ザ ユニバーシティー オブ オレゴン |
Dnaメチル化の阻害剤
|
DE10154317B4
(de)
|
2001-10-26 |
2005-06-09 |
Epigenomics Ag |
Verfahren zum Nachweis von Cytosin-Methylierungen in immobilisierten DNA Proben
|
EP1340818A1
(de)
|
2002-02-27 |
2003-09-03 |
Epigenomics AG |
Verfahren und Nukleinsäuren zur Analyse von Kolonkrebszellen
|
US6890736B1
(en)
|
2002-09-20 |
2005-05-10 |
Immunex Corporation |
Methods for producing proteins in cultured cells
|
EP1554407B1
(de)
|
2002-10-01 |
2009-07-29 |
Epigenomics AG |
Verfahren für die behandlung von proliferativen erkrankungen von brustzellen
|
WO2004046312A2
(en)
*
|
2002-11-15 |
2004-06-03 |
The Board Of Trustees Of The University Of Illinois |
Methods for in vitro expansion of hematopoietic stem cells
|
AU2003902704A0
(en)
*
|
2003-05-29 |
2003-06-19 |
Crc For Waste Management And Pollution Control Limited Of Unsw |
Process for producing a nanoscale zero-valent metal
|
ATE494390T1
(de)
|
2003-06-23 |
2011-01-15 |
Epigenomics Ag |
Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen
|
CA2531451A1
(en)
|
2003-06-23 |
2005-01-06 |
Epigenomics Ag |
Methods and nucleic acids for analyses of colorectal cell proliferative disorders
|
EP2354250A1
(de)
|
2003-06-23 |
2011-08-10 |
Epigenomics AG |
Verfahren und Nukleinsäuren zur Analyse von Störungen der Proliferation kolorektaler Zellen
|
US20050123944A1
(en)
*
|
2003-08-01 |
2005-06-09 |
U.S. Genomics, Inc. |
Methods and compositions related to the use of sequence-specific endonucleases for analyzing nucleic acids under non-cleaving conditions
|
WO2005054517A2
(en)
|
2003-12-01 |
2005-06-16 |
Epigenomics Ag |
Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
|
EP1692316A2
(de)
|
2003-12-11 |
2006-08-23 |
Epigenomics AG |
Verfahren und nukleinsäuren zur verbesserten behandlung von proliferationsstörungen von brustzellen
|
US8415315B2
(en)
|
2004-05-06 |
2013-04-09 |
University Of Central Florida Research Foundation, Inc. |
Methods and compositions for inhibiting the proliferation of cancer cells
|
EP1778865A1
(de)
|
2004-06-23 |
2007-05-02 |
Epigenomics AG |
Verfahren und nukleinsäuren zum nachweis der metastasierung proliferativer kolonzellerkrankungen
|
EP2302073A1
(de)
|
2004-07-18 |
2011-03-30 |
Epigenomics AG |
Epigenetische Verfahren und Nukleinsäuren für den Nachweis von proliferativen Erkrankungen von Mammazellen
|
ATE438740T1
(de)
|
2004-12-02 |
2009-08-15 |
Epigenomics Ag |
Verfahren und nukleinsäuren zur analyse von mit der prognose von störungen der proliferation von prostatazellen assoziierter genexpression
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
WO2006107751A2
(en)
*
|
2005-04-01 |
2006-10-12 |
Methylgene, Inc. |
Combined therapy utilizing reduction of dna methyltansferase expression and/or activity and interferon
|
ES2533767T3
(es)
|
2005-04-15 |
2015-04-15 |
Epigenomics Ag |
Métodos para el análisis de trastornos proliferativos celulares
|
EP2395101B1
(de)
|
2005-05-02 |
2013-11-13 |
University of Southern California |
Mit CpG-Insel-Methylatorphänotyp (CIMP) in menschlichem Kolorektalkrebs assoziierte DNA-Methylierungsmarker
|
MX2007014616A
(es)
|
2005-05-20 |
2009-08-12 |
Methylgene Inc |
Inhibidores de señalizacion del receptor del factor a de crecimiento endotelial vascular y del receptor del factor de crecimiento de hepatocitos.
|
US7700567B2
(en)
|
2005-09-29 |
2010-04-20 |
Supergen, Inc. |
Oligonucleotide analogues incorporating 5-aza-cytosine therein
|
EP1934369A2
(de)
|
2005-09-29 |
2008-06-25 |
Epigenomics AG |
Verfahren und nukleinsäuren zur analyse der mit gewebeklassifizierung assoziierten genexpression
|
CN103301475B
(zh)
|
2005-12-28 |
2016-08-03 |
斯克里普斯研究所 |
药物组合物和表达载体以及调节基因表达的方法和核酸分子的应用
|
WO2007107005A1
(en)
*
|
2006-03-22 |
2007-09-27 |
Methylgene, Inc. |
Inhibitors of protein tyrosine kinase activity
|
CA2649777C
(en)
|
2006-04-17 |
2018-08-14 |
Epigenomics Ag |
Methods and nucleic acids for the detection of colorectal cell proliferative disorders
|
US20080004273A1
(en)
*
|
2006-05-30 |
2008-01-03 |
Stephane Raeppel |
Inhibitors of protein tyrosine kinase activity
|
ES2599816T3
(es)
|
2006-07-21 |
2017-02-03 |
Epigenomics Ag |
Métodos relacionados con el gen GLI3 para la detección de cáncer colorrectal
|
US20080255155A1
(en)
*
|
2006-10-18 |
2008-10-16 |
Stephane Raeppel |
Kinase inhibitors and uses thereof
|
AU2007324702A1
(en)
|
2006-11-24 |
2008-05-29 |
Epigenomics Ag |
Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
|
CA2675895C
(en)
|
2007-01-19 |
2016-03-22 |
Epigenomics Ag |
Methods and nucleic acids for analyses of cell proliferative disorders
|
EP2302069A1
(de)
|
2007-12-11 |
2011-03-30 |
Epigenomics AG |
Verfahren und Nukleinsäuren für Analysen von Zellwucher-Störungen
|
AU2009303602B2
(en)
|
2008-10-14 |
2012-06-14 |
Sunshine Lake Pharma Co., Ltd. |
Compounds and methods of use
|
MX2011005910A
(es)
|
2008-12-04 |
2011-06-17 |
Opko Curna Llc |
Tratamiento de enfermedades relacionadas con eritropoyetina (epo) mediante inhibicion del transcrito antisentido natural a eritropoyetina.
|
CA2746003C
(en)
|
2008-12-04 |
2020-03-31 |
Opko Curna, Llc |
Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
|
US20110294870A1
(en)
|
2008-12-04 |
2011-12-01 |
Opko Curna, Llc |
Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
|
KR101682735B1
(ko)
|
2009-02-12 |
2016-12-06 |
큐알엔에이, 인크. |
뇌 유래된 신경영양성 인자 (bdnf)에 대한 자연 안티센스 전사체의 저해에 의한 뇌 유래된 신경영양성 인자 (bdnf) 관련된 질환의 치료
|
WO2010107733A2
(en)
|
2009-03-16 |
2010-09-23 |
Curna, Inc. |
Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2
|
CN102549159B
(zh)
|
2009-03-17 |
2016-08-10 |
库尔纳公司 |
通过抑制针对δ样1同源物(DLK1)的天然反义转录物来治疗DLK1相关的疾病
|
KR101835889B1
(ko)
|
2009-05-06 |
2018-03-08 |
큐알엔에이, 인크. |
지질 수송 및 대사 유전자에 대한 천연 안티센스 전사체의 억제에 의해 지질 수송 및 대사 유전자 관련된 질환의 치료
|
CA2761142C
(en)
|
2009-05-06 |
2021-06-08 |
Opko Curna, Llc |
Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
|
US9012139B2
(en)
|
2009-05-08 |
2015-04-21 |
Curna, Inc. |
Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family
|
DK2432881T3
(en)
|
2009-05-18 |
2018-02-26 |
Curna Inc |
TREATMENT OF REPROGRAMMING FACTOR-RELATED DISEASES BY INHIBITING NATURAL ANTISENSE TRANSCRIPTS TO A REPROGRAMMING FACTOR
|
WO2010135695A2
(en)
|
2009-05-22 |
2010-11-25 |
Curna, Inc. |
TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3
|
CN103221541B
(zh)
|
2009-05-28 |
2017-03-01 |
库尔纳公司 |
通过抑制抗病毒基因的天然反义转录物来治疗抗病毒基因相关疾病
|
ES2629339T3
(es)
|
2009-06-16 |
2017-08-08 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con la paraoxonasa 1 (pon1) por inhibición de transcrito antisentido natural a pon1
|
JP5944311B2
(ja)
|
2009-06-16 |
2016-07-05 |
クルナ・インコーポレーテッド |
コラーゲン遺伝子に対する天然アンチセンス転写物の抑制によるコラーゲン遺伝子関連疾患の治療
|
CA2765889A1
(en)
|
2009-06-24 |
2010-12-29 |
Opko Curna, Llc |
Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
|
KR101807324B1
(ko)
|
2009-06-26 |
2017-12-08 |
큐알엔에이, 인크. |
다운 증후군 유전자에 대한 천연 안티센스 전사체의 억제에 의한 다운 증후군 유전자 관련된 질환의 치료
|
WO2010149782A1
(en)
|
2009-06-26 |
2010-12-29 |
Epigenomics Ag |
Methods and nucleic acids for analysis of bladder cell proliferative disorders
|
CA2768947C
(en)
|
2009-07-24 |
2018-06-19 |
Opko Curna, Llc |
Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
|
WO2011017516A2
(en)
|
2009-08-05 |
2011-02-10 |
Curna, Inc. |
Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins)
|
EP2464731B1
(de)
|
2009-08-11 |
2016-10-05 |
CuRNA, Inc. |
Behandlung von adiponectin (adipoq)-bedingten erkrankungen mittels hemmung des natürlichen antisense-transkripts gegen ein adiponectin (adipoq)
|
EP2982755B1
(de)
|
2009-08-21 |
2020-10-07 |
CuRNA, Inc. |
Behandlung von erkrankungen im zusammenhang mit c-terminus des hsp70-interagierenden proteins (chip) durch hemmung des natürlichen antisense-transkripts gegen chip
|
EP2470657B1
(de)
|
2009-08-25 |
2019-10-23 |
CuRNA, Inc. |
Behandlung von iqgap ('iq-motiv-haltiges gtpase-aktivierendes protein')-bedingten erkrankungen mittels hemmung des natürlichen antisense-transkripts gegen iqgap
|
DK2480669T3
(en)
|
2009-09-25 |
2018-02-12 |
Curna Inc |
TREATMENT OF FILAGGRIN- (FLG) RELATED DISEASES BY MODULATING FLG EXPRESSION AND ACTIVITY
|
US20110104695A1
(en)
|
2009-11-05 |
2011-05-05 |
Epigenomics Ag |
Methods of predicting therapeutic efficacy of cancer therapy
|
CA2782366A1
(en)
|
2009-12-16 |
2011-07-14 |
Opko Curna, Llc |
Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1
|
WO2011079261A2
(en)
|
2009-12-23 |
2011-06-30 |
Curna, Inc. |
Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
|
US9068183B2
(en)
|
2009-12-23 |
2015-06-30 |
Curna, Inc. |
Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2
|
RU2611186C2
(ru)
|
2009-12-29 |
2017-02-21 |
Курна, Инк. |
ЛЕЧЕНИЕ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С ОПУХОЛЕВЫМ БЕЛКОМ 63 (р63), ПУТЕМ ИНГИБИРОВАНИЯ ПРИРОДНОГО АНТИСМЫСЛОВОГО ТРАНСКРИПТА К р63
|
EP2519633B1
(de)
|
2009-12-29 |
2017-10-25 |
CuRNA, Inc. |
Behandlung von erkrankungen im zusammenhang mit dem nuclear-respirator-faktor 1 (nrf1) mittels hemmung des natürlichen antisense-transkripts gegen nrf1
|
RU2016115782A
(ru)
|
2009-12-31 |
2018-11-28 |
Курна, Инк. |
Лечение заболеваний, связанных с субстратом рецептора инсулина 2 (irs2), путем ингибирования природного антисмыслового транскрипта к irs2 и транскрипционному фактору е3 (tfe3)
|
US8946181B2
(en)
|
2010-01-04 |
2015-02-03 |
Curna, Inc. |
Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8
|
WO2011085066A2
(en)
|
2010-01-06 |
2011-07-14 |
Curna, Inc. |
Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
|
EP2524039B1
(de)
|
2010-01-11 |
2017-11-29 |
CuRNA, Inc. |
Behandlung von krankheiten im zusammenhang mit dem sexualhormonbindenden globulin (shgb) mittels hemmung des natürlichen antisense-transkripts gegen shbg
|
RU2611192C2
(ru)
|
2010-01-25 |
2017-02-21 |
Курна, Инк. |
ЛЕЧЕНИЕ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С РНКазой Н1, ПУТЕМ ИНГИБИРОВАНИЯ ПРИРОДНОГО АНТИСМЫСЛОВОГО ТРАНСКРИПТА К РНКазе Н1
|
KR101838308B1
(ko)
|
2010-02-22 |
2018-03-13 |
큐알엔에이, 인크. |
피롤린-5-카르복실레이트 환원효소 1(pycr1)에 대한 천연 안티센스 전사체의 억제에 의한 pycr1과 관련된 질환의 치료
|
US8980856B2
(en)
|
2010-04-02 |
2015-03-17 |
Curna, Inc. |
Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3
|
RU2610661C2
(ru)
|
2010-04-09 |
2017-02-14 |
Курна, Инк. |
Лечение заболеваний, связанных с фактором роста фибробластов 21 (fgf21), путем ингибирования природного антисмыслового транскрипта к fgf21
|
RU2693462C2
(ru)
|
2010-05-03 |
2019-07-03 |
Курна, Инк. |
Лечение заболеваний, связанных с сиртуином (sirt), путем ингибирования природного антисмыслового транскрипта к сиртуину (sirt)
|
TWI586356B
(zh)
|
2010-05-14 |
2017-06-11 |
可娜公司 |
藉由抑制par4天然反股轉錄本治療par4相關疾病
|
EP2576783B1
(de)
|
2010-05-26 |
2017-11-29 |
CuRNA, Inc. |
Behandlung von durch atonal homolog 1 (atoh1) vermittelten erkrankungen durch hemmung des natürlichen antisense-transkripts für atoh1
|
JP5917497B2
(ja)
|
2010-05-26 |
2016-05-18 |
カッパーアールエヌエー,インコーポレイテッド |
メチオニンスルホキシドレダクターゼa(msra)に対する天然アンチセンス転写物の阻害によるmsra関連疾患の治療
|
JP6023705B2
(ja)
|
2010-06-23 |
2016-11-09 |
カッパーアールエヌエー,インコーポレイテッド |
ナトリウムチャネル、電位依存性、αサブユニット(SCNA)に対する天然アンチセンス転写物の阻害によるSCNA関連疾患の治療
|
JP5998131B2
(ja)
|
2010-07-14 |
2016-09-28 |
カッパーアールエヌエー,インコーポレイテッド |
Discslargehomolog(dlg)dlg1への天然アンチセンス転写物の阻害によるdlg関連疾患の治療
|
ES2640755T3
(es)
|
2010-10-06 |
2017-11-06 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con la Sialidasa 4 (neu4) mediante inhibición del transcrito antisentido natural al gen neu4
|
EP2630241B1
(de)
|
2010-10-22 |
2018-10-17 |
CuRNA, Inc. |
Behandlung von alpha-l-iduronidase (idua)-bedingten erkrankungen mittels hemmung des natürlichen antisense-transkripts gegen idua
|
WO2012068340A2
(en)
|
2010-11-18 |
2012-05-24 |
Opko Curna Llc |
Antagonat compositions and methods of use
|
US8987225B2
(en)
|
2010-11-23 |
2015-03-24 |
Curna, Inc. |
Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG
|
CA2820709C
(en)
|
2011-02-28 |
2016-02-16 |
Sunshine Lake Pharma Co., Ltd. |
Substituted quinoline compounds and methods of use
|
ES2653247T3
(es)
|
2011-06-09 |
2018-02-06 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con la frataxina (FXN) mediante inhibición del transcrito antisentido natural al gen FXN
|
CA2840149C
(en)
|
2011-07-08 |
2021-10-26 |
Epigenomics Ag |
Methods and nucleic acids for determining the prognosis of a cancer subject
|
KR102004559B1
(ko)
|
2011-08-30 |
2019-07-26 |
아스텍스 파마수티컬스, 인크. |
데시타빈 유도체 제제
|
CN108272782B
(zh)
|
2011-09-06 |
2021-04-23 |
库尔纳公司 |
小分子在制备治疗Dravet综合征或全面性癫痫伴热性惊厥附加症的药物中的用途
|
US20150031750A1
(en)
|
2012-03-15 |
2015-01-29 |
The Scripps Research Institute |
Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
|
EP2879677B1
(de)
|
2012-07-28 |
2017-06-14 |
Calitor Sciences, LLC |
Substituierte pyrazolonverbindungen und verfahren zur verwendung
|
TWI574962B
(zh)
|
2012-11-14 |
2017-03-21 |
加拓科學公司 |
作爲pi3激酶調節劑的芳雜環化合物及其使用方法和用途
|
RU2672910C9
(ru)
|
2013-02-21 |
2019-06-04 |
Калитор Сайенсез, ЛЛС |
Гетероароматические соединения как модуляторы фосфоинозитид-3-киназы
|
CN105378108A
(zh)
|
2013-03-13 |
2016-03-02 |
雅培分子公司 |
用于分离核酸的系统和方法
|
JP2016512437A
(ja)
|
2013-03-14 |
2016-04-28 |
アボツト・モレキユラー・インコーポレイテツド |
多重メチル化特異的増幅システムおよび方法
|
ES2859645T3
(es)
|
2013-03-14 |
2021-10-04 |
Mayo Found Medical Education & Res |
Detección de neoplasia
|
WO2015124921A1
(en)
|
2014-02-19 |
2015-08-27 |
The University Court Of The University Of Edinburgh |
Methods and uses for determining the presence of inflammatory bowel disease
|
EP4234722A3
(de)
|
2014-03-31 |
2023-09-20 |
Mayo Foundation for Medical Education and Research |
Detektion von kolorektalem neoplasma
|
CN113981057A
(zh)
|
2014-12-12 |
2022-01-28 |
精密科学公司 |
用于进行甲基化检测测定的组合物和方法
|
EP3274440A4
(de)
|
2015-03-27 |
2019-03-06 |
Exact Sciences Corporation |
Nachweis von erkrankungen der speiseröhre
|
JP6768722B2
(ja)
|
2015-07-02 |
2020-10-14 |
大塚製薬株式会社 |
凍結乾燥医薬組成物
|
AU2016343517B2
(en)
|
2015-10-19 |
2020-04-30 |
Sunshine Lake Pharma Co., Ltd. |
A salt of EGFR inhibitor, crystalline form and uses thereof
|
AU2016343937B2
(en)
|
2015-10-30 |
2023-01-19 |
Exact Sciences Corporation |
Multiplex amplification detection assay and isolation and detection of DNA from plasma
|
KR20170050916A
(ko)
*
|
2015-11-02 |
2017-05-11 |
연세대학교 산학협력단 |
유전자 구조 내 CpG 섬의 후성 유전학적 변형을 통한 줄기세포의 분화 조절 방법
|
CA3022911A1
(en)
|
2016-05-05 |
2017-11-09 |
Exact Sciences Development Company, Llc |
Detection of lung neoplasia by analysis of methylated dna
|
EP3978624A1
(de)
|
2016-07-19 |
2022-04-06 |
Exact Sciences Corporation |
Methylierte kontroll-dna
|
CN116064795A
(zh)
|
2016-09-02 |
2023-05-05 |
梅约医学教育与研究基金会 |
确定差异甲基化区域的甲基化状态的方法和试剂盒
|
EP3574110A4
(de)
|
2017-01-27 |
2021-01-13 |
Exact Sciences Development Company, LLC |
Nachweis von dickdarmneoplasien durch analyse von methylierter dna
|
BR112020002280A2
(pt)
|
2017-08-03 |
2020-07-28 |
Otsuka Pharmaceutical Co., Ltd. |
composto farmacológico e métodos purificação do mesmo
|
US20220017966A1
(en)
|
2018-11-16 |
2022-01-20 |
Oslo Universitetssykehus Hf |
Methods and compositions for characterizing bladder cancer
|
CN111321210B
(zh)
*
|
2018-12-13 |
2021-09-14 |
贵阳优乐复生医学检验所有限公司 |
一种无创产前检测胎儿是否患有遗传疾病的方法
|
JP2022553575A
(ja)
|
2019-10-31 |
2022-12-23 |
マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ |
卵巣癌の検出
|
JP2023539128A
(ja)
|
2020-08-19 |
2023-09-13 |
マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ |
非ホジキンリンパ腫の検出
|
JP2024506854A
(ja)
|
2021-01-29 |
2024-02-15 |
マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ |
複数の種類のがんの有無の検出
|